¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°æÈñ´ëÇб³º´¿ø °æÈñ½ÅÀ忬¼ö °­ÁÂ/ ´ëÇÑ ÀüÇØÁú ÇÐȸ Ãß°è Çмú´ëȸ : 2019-01-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°æÈñ´ëÇб³º´¿ø °æÈñ½ÅÀ忬¼ö °­ÁÂ/ ´ëÇÑ ÀüÇØÁú ÇÐȸ Ãß°è Çмú´ëȸ : 2019-01-20
±³À°ÀÏÀÚ : 2019-01-20
±³À°Àå¼Ò : °æÈñ´ëÇб³ Á¾ÇÕ°­Àǵ¿ ÁöÇÏ 1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : °æÈñ½ÅÀ忬¼ö °­ÁÂ/ ´ëÇÑ ÀüÇØÁú ÇÐȸ Ãß°è Çмú´ëȸ
ÁÖÃÖ±â°ü : °æÈñ´ëÇб³º´¿ø
´ã´çÀÚ : Á¶¹Ì¿µ
¿¬¶ôó : 02-958-8199  
À̸ÞÀÏ : kmcim@naver.com      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüÁ¢¼ö½Ã 30000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-20 °­´ç 09:00~09:20 Biomarker and precision medicine in IgA nephropathy  Á¤°æȯ(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 09:20~09:40 Recent update of Pathology in IgA nephropathy  ¼ºÁö¿¬(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 09:40~10:00 Knowhow to manage the IgA nephropathy patients  ÀÓõ±Ô(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 10:30~10:50 How succefully manage the catheter dysfunction in HD patients?  È²Çö¼®(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 10:50~11:10 Paricalcitol, cinacalcet and etecalcetide: What is difference?  ±è¾ç±Õ(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 11:10~11:30 How to manage the failed graft after kidney transplantation?  ÀÌÅ¿ø(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 13:00~13:30 Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk  ±èÈ¿»ó(¿ï»ê´ë) 
±³À°½Ã°£ 01-20 °­´ç 13:30~14:00 Ups and downs of dialysate calcium concentration in hemodialysis  ÀÌ»óÈ£(°æÈñ´ë) 
±³À°½Ã°£ 01-20 °­´ç 14:00~14:30 Automated blood pressure and CKD progression  À¯ÅÂÇö(¿¬¼¼´ë) 
±³À°½Ã°£ 01-20 °­´ç 14:30~15:00 Blood pressure targets for hemodialysis patients  ¹èÀºÈñ(Àü³²´ë) 
Åä·Ð 01-20 °­´ç 15:00~15:30 Panel discussion  ÀÌâȭ°í°­Áö±è¼¼Áß°­¼±¿ì(ÇѾç´ë°í·Á´ë¼­¿ï´ëÀÎÁ¦´ë) 
±³À°½Ã°£ 01-20 °­´ç 15:30~16:30 Interesting and educational cases  ·ùµ¿¿­¹ÚÁؼºÃÖ´ëÀº(ÀÌÈ­¿©´ëÇѾç´ëÃæ³²´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °æÈñ´ëÇб³º´¿ø °æÈñ½ÅÀ忬¼ö °­ÁÂ/ ´ëÇÑ ÀüÇØÁú ÇÐȸ Ãß°è Çмú´ëȸ : 2019-01-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼øõÇâ´ëÇб³ºÎõº´¿ø ±¸³»¿° ¹× ±¸°­³» º´º¯ : 2018-12-21
´ÙÀ½±Û ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø °³¿øÀÇ Áø·á¸¦ À§ÇÑ ¼Ò¾Æû¼Ò³â°ú ÁúȯÀÇ »õ·Î¿î Á¢±Ù°ú ÀÌÇØ : 2019-01-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
399 °­¿ø Ãáõ½ÃÀÇ»çȸ Ãß°è ¿¬¼ö°­Á : 2018-09-03 0 833 2018-08-15
398 ¼­¿ï Á¦1ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ´ë»çºñ¸¸¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-02 0 878 2018-08-15
397 °æ±â ´ëÇÑÃÊÀ½ÆÄÀÇÇÐȸ º¹ºÎ ÃÊÀ½ÆÄ °Ë»ç ÀÔ¹®±³À°: °­ÀÇ ¹× ½Ç½À : 2018-09-02 0 809 2018-08-15
396 ºÎ»ê ´ëÇÑ°©»ó¼±¿µ»óÀÇÇÐȸ Á¦1ȸ Áö¿ª ½ÉÈ­ Hands-on ±³À° : 2018-09-02 0 847 2018-08-15
395 ºÎ»ê Á¦15ȸºÎ¿ï°æÇǺΰúÀÇ»çȸÇмú´ëȸ : 2018-09-02 0 3,127 2018-08-15
394 ¼­¿ï 2018 °­µ¿°æÈñ´ëÇб³º´¿ø »êºÎÀΰúÇб³½Ç ¿¬¼ö°­Á : 2018-09-02 0 1,180 2018-08-15
393 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ º¸Åø¸®´®-ÇÊ·¯ ¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2018-09-02 0 668 2018-08-15
392 ÃæºÏ ÃæºÏ´ëÇб³º´¿ø 2018³â Á¦ 5ȸ ´ëÀüÃæû Á·ºÎÁ·°üÀý ½ÉÆ÷Áö¾ö : 2018-09-02 0 928 2018-08-15
391 ¼­¿ï Preterm Birth International Collaborative Australasian(´ëÇÑ»êºÎÀΰúÇÐȸ&¼¼°èÁ¶»êÇÐȸ °øµ¿ÁÖ°ü) : 2018-09-01 0 745 2018-08-15
390 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø 2018³â ¾ÆÁÖ´ëÇб³ ¸¶ÃëÅëÁõÀÇÇаú Ãß°è Çмú´ëȸ : 2018-09-01 0 1,217 2018-08-15
389 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-09-01 0 554 2018-08-15
388 °æ³² â¿ø°æ»ó´ëÇб³º´¿ø 2018³â Áߺΰ泲 ¿¬¼ö±³À° : 2018-09-01 0 901 2018-08-15
387 °­¿ø Á¦19ȸ ´ëÇÑ Ã´Ãß¿Ü°úÇÐȸ ôÃßÅëÁõ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2018-09-01 0 827 2018-08-15
386 ºÎ»ê Á¦15ȸºÎ¿ï°æÇǺΰúÀÇ»çȸÇмú´ëȸ : 2018-09-01 0 1,041 2018-08-15
385 ¼­¿ï 2018 ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú Ãß°è ÀÓ»ó ¿öÅ©¼¥ : 2018-09-01 0 759 2018-08-15
1351 | 1352 | 1353 | 1354 | 1355 | 1356 | 1357 | 1358 | 1359 | 1360
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷